Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) research hub

Fibrosis Lessens After Metabolic Surgery

This study looks at how well weight-loss surgery compares to new medicines for treating liver disease. It focuses on a condition called MASH, which is linked to being overweight and can cause liver damage.